Team:Amplino/Solution/Competition

From 2012e.igem.org

(Difference between revisions)
(→Competition)
(→Competition)
 
(3 intermediate revisions not shown)
Line 1: Line 1:
==Competition==
==Competition==
-
In the table below we compare a great number of competitors in the field of medical diagnostics. Not all of them necessarily offer products for Malaria, but we feel the technology they posses might be applicable.
+
Organizations such as UNITAID or the World Health Organisation publish yearly documents on the competitive landscape of malaria diagnostics. The UNITAID report can be found [http://www.unitaid.eu/images/marketdynamics/publications/UNITAID%20Malaria%20Diagnostics%20Market%20Landscape_2012.pdf here].
-
When judging their potential threat, we used a scoring system based on our business and design requirements list.
+
A great number of malaria diagnostics methods already exists, but most of them are still constrained inside laboratories, as shown in the image below (image courtesy of UNITAID)
-
<html>
+
[[File:UNITAID_Malaria_TechnologyLandscape.png]]
-
<table>
+
 
-
<tr>
+
Amplino is about using PCR technologies outside the lab (known as point-of-care). The higher sensitivity will be beneficial especially for pregnant woman. Additionally, PCR allows to discover the kind of malaria species that is involved, which partly determines how lethal the disease is.
-
<td>Name</td>
+
-
<td>Company</td>
+
-
<td>Type</td>
+
-
<td>Speed</td>
+
-
<td>Sample</td>
+
-
<td>Cost</td>
+
-
<td>Requirements</td>
+
-
<td>Application</td>
+
-
<td>Picture</td>
+
-
</tr>
+
-
<tr>
+
-
<td><a href="http://www.axelabiosensors.com/real-time-immunoassays/dotlab-system.php">dotLab</a></td>
+
-
<td>Alexa</td>
+
-
<td>real time Immuno Assay</td>
+
-
<td>15 - 90 min</td>
+
-
<td>Blood</td>
+
-
<td>tbd</td>
+
-
<td>100-240V, 250W</td>
+
-
<td></td>
+
-
<td><img src="https://static.igem.org/mediawiki/2012e/a/a5/AMPLINO-dotLab.jpg" width=250 /></td>
+
-
</tr>
+
-
<tr>
+
-
<td><a href="http://dfa.org/">Patterned Paper</a></td>
+
-
<td>Diagnostics for All</td>
+
-
<td>Immuno Assay</td>
+
-
<td>10 min</td>
+
-
<td>Blood</td>
+
-
<td>tbd</td>
+
-
<td>none</td>
+
-
<td>Liver test in development</td>
+
-
<td><img src="https://static.igem.org/mediawiki/2012e/d/d2/AMPLINO-dfa.png" width=250 /></td>
+
-
</tr>
+
-
<tr>
+
-
<td><a href="http://www.inbios.com/rapid-tests/malaria-detect-pfpv">Malaria Pf/Pv Detect</a></td>
+
-
<td>InBios</td>
+
-
<td>Immuno Assay</td>
+
-
<td>10 min</td>
+
-
<td>Serum</td>
+
-
<td>tbd</td>
+
-
<td>Centrifuge</td>
+
-
<td>Malaria</td>
+
-
<td><img src="https://static.igem.org/mediawiki/2012e/1/11/AMPLINO-InBios.jpg" width=250 /></td>
+
-
</tr>
+
-
<tr>
+
-
<td><a href="http://www.orasure.com/products-infectious/products-infectious-oraquick.asp">OraQuick</a></td>
+
-
<td>OraSure</td>
+
-
<td>Immuno Assay</td>
+
-
<td>40 min</td>
+
-
<td>Salvia</td>
+
-
<td>tbd</td>
+
-
<td>none</td>
+
-
<td>HIV</td>
+
-
<td><img src="https://static.igem.org/mediawiki/2012e/7/72/AMPLINO-OraQuick.jpg" height=170 /></td>
+
-
</tr>
+
-
<tr>
+
-
<td><a href="http://www.clarosdx.com/technology.php">Handheld Analyzer</a></td>
+
-
<td>Claros</td>
+
-
<td>Immuno Assay</td>
+
-
<td>15 min</td>
+
-
<td>Blood</td>
+
-
<td>$100 per device</td>
+
-
<td>none</td>
+
-
<td>HIV, syphilis and anemia in development</td>
+
-
<td><img src="https://static.igem.org/mediawiki/2012e/a/aa/Amplino-Claros.jpg" height=170 /></td>
+
-
</table>
+
-
</html>
+

Latest revision as of 15:27, 21 October 2012

Competition

Organizations such as UNITAID or the World Health Organisation publish yearly documents on the competitive landscape of malaria diagnostics. The UNITAID report can be found [http://www.unitaid.eu/images/marketdynamics/publications/UNITAID%20Malaria%20Diagnostics%20Market%20Landscape_2012.pdf here].

A great number of malaria diagnostics methods already exists, but most of them are still constrained inside laboratories, as shown in the image below (image courtesy of UNITAID)

UNITAID Malaria TechnologyLandscape.png

Amplino is about using PCR technologies outside the lab (known as point-of-care). The higher sensitivity will be beneficial especially for pregnant woman. Additionally, PCR allows to discover the kind of malaria species that is involved, which partly determines how lethal the disease is.

Retrieved from "http://2012e.igem.org/wiki/index.php/Team:Amplino/Solution/Competition"